• Space

    INVESTOR DAY Visit us in Lisbon, Portugal, on March 12th for a tour of our operations and presentations on the financials perspectives and the regulatory framework in Portugal. The activities begin at 8:30 Am and end at 16:00 RSVP info@exmceuticals.com

    Learn More

Medical grade ingredients

EXMceuticals (“EXM”) is a medical cannabis company that strongly believes in the potential health and wellness benefits of hemp and cannabis.  EXM is an emerging player in the market, with ambition and potential to become one of the world's suppliers of highest-grade cannabis ingredients.  EXM is currently creating an industrial-scale, GMP, and Pharmaceutical Grade extraction and refining unit inside the European Union, near Lisbon Portugal. EXM has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients to the pharmaceutical, medicinal and wellness industry

EXMceuticals_icons_extract.png

Research Driven

Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists

EXMceuticals_icons_organic.png

Innovation

Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.

EXMceuticals_icons_medical.png

Medical

Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry. We control our cultivation, extraction, refining and manufacturing practices

EXMceuticals_icons_scalable.png

Flexible Revenue Model

Our state-of-the-art testing lab is equipped to conduct all quality control testing for third parties. Processing Services to transform biomass or oil into high-grade extracts and white labelling services in the creation of custom extracts for specific product formulations.

Exchange Price % Move
CSE:EXM
FSE:A2PAW2

Investor information

EXMceuticals Inc. Sets its Sights firmly on the estimated €200 Billion value of the combined European and US cannabis market in 2028 .

Our Portuguese extraction and refinery hub will process the raw materials produced by EXMFarming, as well as those sourced from 3rd party growers in both Portugal and Internationally. Portugal will serve as the gateway to distribute pure ingredients across Europe and into North America & Asia.

Learn more

Updates

News

Latest News

Access our latest news

lab-217041.jpg

Research and Development

EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...

Lab.jpeg

EXMceuticals obtains its research and development

EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...

2% of the gross revenues from each of our plantations is allocated to projects that will improve living conditions and further the development of local communities. Projects include clean drinking water, education and sustainable production of food crops.

Learn More